<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The subcutaneous implantable cardioverter-defibrillator is a novel device that does not require insertion of a transvenous lead; rather, it delivers 80-J transthoracic shocks via a subcutaneous pulse generator implanted in the left lateral chest and a subcutaneous left parasternal lead-electrode </plain></SENT>
<SENT sid="1" pm="."><plain>It recently received approval by U.S </plain></SENT>
<SENT sid="2" pm="."><plain>Food and Drug Administration panel on the basis of a 180-day study in 330 patients </plain></SENT>
<SENT sid="3" pm="."><plain>However, it has not been shown to be non inferior to current implantable cardioverter-defibrillators, and it does not provide either anti-<z:hpo ids='HP_0001649'>tachycardia</z:hpo> or <z:hpo ids='HP_0001662'>bradycardia</z:hpo> pacing </plain></SENT>
<SENT sid="4" pm="?"><plain>Thus, is this technology ready for widespread application </plain></SENT>
<SENT sid="5" pm="?"><plain>Specifically, should a patient want one </plain></SENT>
</text></document>